Cleared Special

MODIFICATION TO OPTIMUM CLEANING, DISINFECTING AND (K014162) - FDA 510(k) Clearance

Class II Ophthalmic device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K014162 · Lobob Laboratories, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2002
Decision
27d
Days
Class 2
Risk

K014162 is an FDA 510(k) clearance for the MODIFICATION TO OPTIMUM CLEANING, DISINFECTING AND. Classified as Products, Contact Lens Care, Rigid Gas Permeable (product code MRC), Class II - Special Controls.

Submitted by Lobob Laboratories, Inc. (Washington, US). The FDA issued a Cleared decision on January 15, 2002 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.5918 - the FDA ophthalmic device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Lobob Laboratories, Inc. devices

Submission Details

510(k) Number K014162 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 2001
Decision Date January 15, 2002
Days to Decision 27 days
Submission Type Special
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
83d faster than avg
Panel avg: 110d · This submission: 27d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MRC Products, Contact Lens Care, Rigid Gas Permeable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.5918
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - MRC Products, Contact Lens Care, Rigid Gas Permeable

All 32
Devices cleared under the same product code (MRC) and FDA review panel - the closest regulatory comparables to K014162.
cleadew GP hydra one
K251876 · Ophtecs Corporation · Oct 2025
Boston One Step Liquid Enzymatic Cleaner
K200416 · Bausch & Lomb, Incorporated · Sep 2020
VibrantVue Scleral Saline
K201069 · Dry Eye Innovations, LLC · Jul 2020
MaxiTears Contacts PF
K182984 · Omnivision AG · Jul 2019
Nutrifill
K181566 · Contamac, Ltd. · Oct 2018
Bausch + Lomb Boston SimplusMulti-Action Solution, Bausch + Lomb Boston One Step Liquid Enzymatic Cleaner
K181627 · Bausch & Lomb, Incorporated · Aug 2018